NCT06941662 · RECRUITING

Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping

This observational study follows people who carry the Huntington's disease gene change. It uses home video, a phone app, wristbands, and blood, urine, and spinal fluid samples to look for measurable signs of how the disease starts and changes. Nothing is being tested as a treatment. No phase is listed.

You may qualify if

  • Individuals with a positive test for the HD expansion mutation.

You're excluded if

  • Individuals with movement disorders with a negative test for the HD expansion mutation.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-04-24

View full record on ClinicalTrials.gov

All APOE4 clinical trials